Financial Analyst Research Coverage
The following equity research analysts provide research coverage on BiondVax’s stock. If you are interested in receiving a research report, please either contact the analysts directly or contact BiondVax’s investor relations, which will attempt to request the reports from the analysts on your behalf.
|Aegis Capital||Robert Leboyer||+1 646 502-2494|
|Zacks Research||David Bautz, PhD||+1 312 265 9471|
|Edison||Dr. Jonas Peciulis||+44 (0)20 3077 5728|